Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply - Cipriani, A; Adamo, N; Giovane, C; Coghill, D; Banaschewski, T; Hollis, C; Zuddas, A; Simonoff, E; Cortese, S (Elsevier, 2018)